neuroendocrine tumors การใช้

• This cancer is considered to be a form of neuroendocrine tumor.
• Neuroendocrine tumors are also a well known cause of secondary hypertension.
• Xenin is also produced in neuroendocrine tumors of the duodenal mucosa.
• A minority arise from islet cells, and are classified as neuroendocrine tumors.
• DNA mutation analysis in well-differentiated pancreatic neuroendocrine tumors identified four important findings:
• A phase II clinical trial for advanced pancreatic neuroendocrine tumors ( pNET ) has reported results.
• Some neuroendocrine tumor cells possess especially strong hormone receptors, such as somatostatin receptors and uptake hormones strongly.
• Imaging with fluorine-18 fluorodeoxyglucose ( FDG ) PET may be valuable to image some neuroendocrine tumors.
• In addition, these neuroendocrine tumors release erythropoietin ( EPO ) into circulating blood, and lead to polycythemia.
• Octreotide scanning is reported to have a sensitivity between 75 % and 100 % for detecting pancreatic neuroendocrine tumors.
• Animal neuroendocrine tumors include neuroendocrine cancer of the liver in dogs, and devil facial tumor disease in Tasmanian devils.
• In anatomical pathology, CD57 ( immunostaining ) is similar to CD56 for use in differentiating neuroendocrine tumors from others.
• This syndrome is of special interest as finding more than one type of neuroendocrine tumor in one individual is unusual.
• Accordingly, paragangliomas are categorised as originating from a neural cell line in the World Health Organization classification of neuroendocrine tumors.
• Mutations in EPAS1 gene are related to early onset of neuroendocrine tumors such as paragangliomas, somatostatinomas and / or pheochromocytomas.
• PanNETs are a type of neuroendocrine tumor, representing about one third of gastroenteropancreatic neuroendocrine tumors ( GEP-NETs ).
• PanNETs are a type of neuroendocrine tumor, representing about one third of gastroenteropancreatic neuroendocrine tumors ( GEP-NETs ).
• Rarely, CUP may appear as neuroendocrine tumors, or mixed tumors, such as sarcomatoid, basaloid, or adenosquamous carcinomas.
• Functional tumors are often classified by the hormone most strongly secreted by the pancreatic neuroendocrine tumor, as discussed in that main article.
• Advances in nuclear medicine imaging, also known as molecular imaging, has improved diagnostic and treatment paradigms in patients with neuroendocrine tumors.